L'esplorazione dell'empowerment di un'istuzione di salute mentale

Il ruolo dell’Ospedale Psichiatrico Giudiziaro è un problema crescente in entrambi i paesi sviluppati e in via di sviluppo. Gli esperti della psichiatria di comunità e dei gruppi di auto aiuto vedono l'empowerment come un fattore chiave per il successo di queste istituzioni. Uno studio quantitativo esplorativo è stato condotto in un ospedale Psichiatrico Giudiziario a Tirana. Questo studio ha misurato l'empowerment del paziente e il personale con l'obiettivo di comprendere la situazione attuale presso l'O. P. G. di Tirana. Questo consentirà alle parti interessate di effettuare un intervento di successo per servire al meglio le esigenze di tutte le parti. Empowerment in psichiatria può essere definito come un progetto attentamente progettata che contribuirà a consentire al personale di aiutare al meglio a soddisfare le esigenze dei pazienti e dei operatori. Pertanto, l’empowerment scale e altri questionari sono stati utilizzati sia per il paziente e gli operatori del personale dell'O. P. G. di Tirana. I risultati mostrano una differenza significativa tra il personale e i pazienti in materia di empowerment. Correlazioni interessanti sono state trovate tra l’empowerment e dati demografici dei pazienti e il personale dell'Ospedale Psichiatrico Giudiziario di Tirana. Una correlazione positiva tra empowerment e alcuni elementi della qualità di vita dei pazienti. Si è anche trovato che l’empowerment dipendeva dalla gravità dei sintomi. E' molto importante avere un intervento concreto che prevede di aumentare il livello dell’empowerment nel personale e nei pazienti presso l'Ospedale Psichiatrico Giudiziario di Tirana.

Drug of abuse analysis: new methods in herbal and biological matrices for medicinal chemistry and forensic investigation

In this Ph.D. project, original and innovative approaches for the quali-quantitative analysis of abuse substances, as well as therapeutic agents with abuse potential and related compounds were designed, developed and validated for application to different fields such as forensics, clinical and pharmaceutical. All the parameters involved in the developed analytical workflows were properly and accurately optimised, from sample collection to sample pretreatment up to the instrumental analysis. Advanced dried blood microsampling technologies have been developed, able of bringing several advantages to the method as a whole, such as significant reduction of solvent use, feasible storage and transportation conditions and enhancement of analyte stability. At the same time, the use of capillary blood allows to increase subject compliance and overall method applicability by exploiting such innovative technologies. Both biological and non-biological samples involved in this project were subjected to optimised pretreatment techniques developed ad-hoc for each target analyte, making also use of advanced microextraction techniques. Finally, original and advanced instrumental analytical methods have been developed based on high and ultra-high performance liquid chromatography (HPLC,UHPLC) coupled to different detection means (mainly mass spectrometry, but also electrochemical, and spectrophotometric detection for screening purpose), and on attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) for solid-state analysis. Each method has been designed to obtain highly selective, sensitive yet sustainable systems and has been validated according to international guidelines. All the methods developed herein proved to be suitable for the analysis of the compounds under investigation and may be useful tools in medicinal chemistry, pharmaceutical analysis, within clinical studies and forensic investigations.

Study of the urinary biomarkers of synthetic cannabinoid receptor agonists (SCRAs) for the forensic unequivocal proof of consumption: medico-legal implications for drug abuse prevention

Introduction. Synthetic cannabinoid receptor agonists (SCRAs) represent the widest group of New Psychoactive Substances (NPS) and, around 2021-2022, new compounds emerged on the market. The aims of the present research were to identify suitable urinary markers of Cumyl-CB-MEGACLONE, Cumyl-NB-MEGACLONE, Cumyl-NB-MINACA, 5F-EDMB-PICA, EDMB-PINACA and ADB-HEXINACA, to present data on their prevalence and to adapt the methodology from the University of Freiburg to the University of Bologna. Materials and methods. Human phase-I metabolites detected in 46 authentic urine samples were confirmed in vitro with pooled human liver microsomes (pHLM) assays, analyzed by liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-qToF-MS). Prevalence data were obtained from urines collected for abstinence control programs. The method to study SCRAs metabolism in use at the University of Freiburg was adapted to the local facilities, tested in vitro with 5F-EDMB-PICA and applied to the study of ADB-HEXINACA metabolism. Results. Metabolites built by mono, di- and tri-hydroxylation were recommended as specific urinary biomarkers to monitor the consumption of SCRAs bearing a cumyl moiety. Monohydroxylated and defluorinated metabolites were suitable proof of 5F-EDMB-PICA consumption. Products of monohydroxylation and amide or ester hydrolysis, coupled to monohydroxylation or ketone formation, were recognized as specific markers for EDMB-PINACA and ADB-HEXINACA. The LC-qToF-MS method was successfully adapted to the University of Bologna, as tested with 5F-EDMB-PICA in vitro metabolites. Prevalence data showed that 5F-EDMB-PINACA and EDMB-PINACA were more prevalent than ADB-HEXINACA, but for a limited period. Conclusion. Due to undetectability of parent compounds in urines and to shared metabolites among structurally related compounds, the identification of specific urinary biomarkers as unequivocal proofs of SCRAs consumption remains challenging for forensic laboratories. Urinary biomarkers are necessary to monitor SCRAs abuse and prevalence data could help in establishing tailored strategies to prevent their spreading, highlighting the role for legal medicine as a service to public health.